- New antimicrobials on the horizon
-
Lee MS
- KMID: 2305799
- Korean J Med.
- 2009 Jul;77(1):35-51.
Recently, infections caused by antibiotic-resistant bacteria continue to climb in the community and the hospital around the world. Our current antimicrobial agents are gradually becoming ineffective and a new pipeline... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
-
Park SH
- KMID: 2128461
- Korean J Med.
- 2014 Apr;86(4):425-431.
Weight loss via lifestyle modification remains the most efficient treatment for NAFLD. Weight loss and exercise are the cornerstones of therapy, but achieving long-term lifestyle modification is not free from... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab(TM)) in High-Risk Patients with Percutaneous Coronary Intervention
-
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y
- KMID: 724253
- Yonsei Med J.
- 2008 Jun;49(3):389-399.
- doi: 10.3349/ymj.2008.49.3.389
PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab(TM). We expected to obtain same results as with ReoPro(R) in improving... -
- CITED
-
- Close
- SHARE
-
- Close
